May 13, 2016
2 min watch
Save

VIDEO: Wigley discusses treatment advances for scleroderma

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

DESTIN, Fla. — At the Congress of Clinical Rheumatology Annual Meeting, Fredrick M. Wigley, MD, spoke about treatment advances for patients with scleroderma. He said the disease expression is heterogeneous and it is important rheumatologists clearly define the clinical phenotype.